Prosecution Insights
Last updated: October 02, 2026
Application No. 18/714,850

METHOD FOR PREPARING OXIME DERIVATIVE

Non-Final OA §102§112
Filed
May 30, 2024
Priority
Nov 30, 2021 — RE 10-2021-0169457 +1 more
Examiner
BAHTA, MEDHANIT W
Art Unit
Tech Center
Assignee
Seoul National University R&DB Foundation
OA Round
1 (Non-Final)
81%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 81% — above average
81%
Career Allowance Rate
640 granted / 794 resolved
+20.6% vs TC avg
Strong +28% interview lift
Without
With
+28.2%
Interview Lift
resolved cases with interview
Fast prosecutor
2y 1m
Avg Prosecution
45 currently pending
Career history
829
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
40.4%
+0.4% vs TC avg
§102
15.7%
-24.3% vs TC avg
§112
29.2%
-10.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 794 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of the Claims A preliminary amendment to the claims has not been filed. Thus claims 1-13 filed on 05/30/2024 are currently pending and are under examination. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-13 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding claim 1, the terms “derivative” in the preamble and “related substituent” in the definition of iPr render the claim vague and indefinite because the terms do not limit the claims to the recited species and thus are unclear as to how much variation of the recited species are tolerated by the use of terms “derivative” and “related substituent”. The rejection is obviated by removing the aforementioned terms. Claims 2-13 are also rendered indefinite for their dependency on claim 1. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – Claims 1 and 5-13 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Padmanaban I (Padmanaban, S. et al. “Nickel-Catalyzed NO Group Transfer Coupled with NOx Conversion” J. Am. Chem. Soc. 2022, 144, 2827−2828, published Feb. 14, 2022; cited in IDS 05/30/2024) as evidenced by Padmanaban II (Supporting information of Padmanaban, S. et al. “Nickel-Catalyzed NO Group Transfer Coupled with NOx Conversion” J. Am. Chem. Soc. 2022, 144, 2827−2828, pages S1-S91; published Feb. 14, 2022) Regarding claims 1, 5-9, 11 and 13, Padmanaban teaches a method for preparing oxime compounds (Fig. 3, reproduced below) that anticipate the claims: PNG media_image1.png 684 479 media_image1.png Greyscale PNG media_image2.png 140 472 media_image2.png Greyscale wherein 5 is the catalyst as follows (from Scheme 1): PNG media_image3.png 135 103 media_image3.png Greyscale Regarding claim 10, the supporting information, Padmanaban II, teaches on page S6 a representative experimental procedure where 1.60 mmol of NaNO2 and 0.53 mmol of (1-bromoethyl)benzene (specie of the first compound) have been used, thus the molar ratio of the first compound to NaNO2 is about 1:3. Regarding claim 12, Table S1, entries 14-16 of the supporting information, Padmanaban II, teaches every limitation of the claim. Allowable Subject Matter The subject matter of claims 2-4 is free of prior art. The closest prior art reference has been set forth above, in which X1 of catalyst 5 is Cl and provides in Scheme 1 a method for preparing the catalyst. However, Padmanaban I fails to teach that X1 is Br as instantly claimed. Furthermore, there is no suggestion in Padmanaban I for a skilled artisan to modify the teachings of the reference to reasonably obtain the catalyst as claimed in which X1 is Br. There is no guidance in Scheme 1 of the reference to modify the synthetic approach to arrive at a catalyst where X1 is Br. In view of the foregoing, Padmanaban I neither anticipates nor reasonably makes obvious claims 2-4. Conclusion Claims 1-13 are rejected and no claims are allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MEDHANIT W BAHTA whose telephone number is (571)270-7658. The examiner can normally be reached Monday-Friday 8am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Goon can be reached at 571-270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MEDHANIT W BAHTA/Primary Examiner, Art Unit 1692
Read full office action

Prosecution Timeline

May 30, 2024
Application Filed
Sep 22, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12735369
Selective Transition Metal Catalyzed Deuterium Incorporation Into Alkyne and Alkene Functionalities
3y 4m to grant Granted Sep 15, 2026
Patent 12735375
PROCESS
3y 6m to grant Granted Sep 15, 2026
Patent 12729174
CONVERTING NATURAL GAS TO DIMETHYL ETHER
3y 8m to grant Granted Sep 08, 2026
Patent 12721800
PHOSPHONATES AND N-HALAMINES COMPOSITIONS FOR TARTAR REMOVAL
3y 2m to grant Granted Sep 01, 2026
Patent 12715882
ADDUCT COMPRISING AT LEAST A METAL SELECTED FROM GOLD, SILVER AND COPPER AND AN ADDUCT OF A CARBON ALLOTROP AND A PYRROLIC COMPOUND
3y 6m to grant Granted Aug 25, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
81%
Grant Probability
99%
With Interview (+28.2%)
2y 1m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 794 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month